Contemporary pharmacological obesity treatments
Journal Title: Current Issues in Pharmacy and Medical Sciences - Year 2016, Vol 29, Issue 2
Abstract
In the last few years, obesity has become a global epidemic. Consequently, worldwide costs associated with managing obesity and obesity-related comorbidities are huge. Numerous studies have focused on discerning the appropriate proper treatment of weight related problems such as overweight and obesity. Moreover, many clinical trials have been conducted for many years in order to introduce effective anti-obesity drugs. The aim of the present review is to provide an overview of current and future pharmacotherapy for obesity, and to provide the reader with a determination of the concentration and composition of long and short term anti-obesity drugs, doing so by placing emphasis on pharmacotherapy and up-to-day solutions. It should be noted that, currently, the worldwide pharmacotherapy is represented by phendimetrazine, benzphetamine and diethylpropion, as well as by orlistat, lorcaserin, phentermine/topiramate, naltrexone/bupropion and liraglutide. In our paper, individual cases of patients’ needs are thoroughly illustrated by way of examples. Medical prescriptions and contraindications are also described.
Authors and Affiliations
Katarzyna Kaszubska, Barbara Budzyńska, Grażyna Biała
Keywords
Related Articles
- EP ID EP90927
- DOI 10.1515/cipms-2016-0012
- Views 131
- Downloads 0
Physical properties and caffeine release from creams prepared with different oils
Caffeine is a methylxanthine typically found in the Coffee Arabica L plant. Generally, caffeine is well-known as a orally administered mild stimulant of the central nervous system. However, for cosmetic purpose, caffeine...
The international normalized ratio (INR) as seen in a population of patients with atrial fibrillation and cerebral infarction undergoing long-term treatment with vitamin K antagonists
It is estimated that nearly 20% of all cerebral infarctions in the total population are the result of a complication of atrial fibrillation (AF). While oral anticoagulation with vitamin K antagonists (AVKs) substantially...
The influence of the viscosity of the ointment vehicles magisterial topical preparations, on the speed transfer of biologically active substances
The aim of this study was to analyze the morphological parameters (viscosity, viscous elasticity and the rate of volatile component loss) of salicylic and boric acid-containing magisterial formulae (ointments). Moreover,...
The antibacterial activity of allyl derivatives of thiosemicarbazide, N1-thiocarbamylamidrazone, 1,2,4-triazole-5-thione, 1,3,4-(thiadiazol-2-yl) amine and derivatives of bicyclic systems: 1,2,4-triazole[3,4-b]1,3-thiazine, 1,2,4-triazole[3,2-b]1,3-thiazine, 1,3,4-thiadiazole[3,2-a]pyrimidine, thiazolo[2,3-c][1,2,4]triazol
The 1-acyl(aroil)-4-(allyl)cinnamyl-thiosemicarbazides (1-9), N1-allyl(cinnamyl)-thiocarbamyl-N3-phenyl-amidrazones (10-12), allyl derivatives of 1,2,4-triazole-5-thione (13- 23), 1,3,4-(thiadiazol-2-yl) amine (24-29), d...
Multiple sclerosis – causes, risk factors and symptoms of the disease - a literature review
Multiple sclerosis (SM) is a classified chronic disease which leads to disability. Apart from severe cases, persons suffering from SM, live on average, as long as healthy people, however, their everyday life is often con...